Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain
β Scribed by Ching-Yue Yang; Chih-Shung Wong; Jang-Yang Chang; Shung-Tai Ho
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- French
- Weight
- 474 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1496-8975
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Current equianalgesic reference tables, based largely on single dose studies, give dose ratios of 1:1 to 4:1 for oral morphine to oral methadone, which possibly are inaccurate in patients with cancer pain who are exposed to multiple doses of these opioids. the purpose of this study w
## Abstract There is emerging data supporting the use of TTSβF (transdermal therapeutic systemβfentanyl) in opioid naive patients. Our study examines the safety and efficacy of TTSβF in the longβterm control of cancer pain in opioid naive patients and those transferring from oral morphine. Pain was